CANADA — Merck will pay a maximum of C$37 million to settle all claims against its painkiller Vioxx in Canada, InPharm reports.
The settlement includes C$10 million in costs and fees, and will total between C$21.8 million and C$37 million (US$36.4 million), depending upon the number of eligible claims.
Vioxx is believed to have caused tens of thousands of heart attacks and sudden cardiac death between its approval in 1999 and 2004, when Merck removed it from the market.
It was one of the firm’s top selling drugs, but Merck had to pay billions of dollars to settle multiple civil and criminal suits, including a $4.9 billion settlementto cover most of its US cases.
Merck continues to deny any wrongdoing.